Kinneret Advisory LLC Buys New Holdings in Mcdonald’s Corp (MCD)

Share on StockTwits

Kinneret Advisory LLC bought a new position in shares of Mcdonald’s Corp (NYSE:MCD) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 20,271 shares of the fast-food giant’s stock, valued at approximately $3,600,000. Mcdonald’s accounts for approximately 1.1% of Kinneret Advisory LLC’s portfolio, making the stock its 23rd largest holding.

A number of other large investors have also recently added to or reduced their stakes in the stock. HC Financial Advisors Inc. boosted its position in Mcdonald’s by 4.9% in the 3rd quarter. HC Financial Advisors Inc. now owns 10,669 shares of the fast-food giant’s stock valued at $1,785,000 after buying an additional 499 shares during the period. Bank of New York Mellon Corp boosted its position in Mcdonald’s by 6,582,167.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 7,964,544 shares of the fast-food giant’s stock valued at $1,332,390,000 after buying an additional 7,964,423 shares during the period. CI Investments Inc. boosted its position in Mcdonald’s by 32,825.0% in the 3rd quarter. CI Investments Inc. now owns 131,700 shares of the fast-food giant’s stock valued at $22,032,000 after buying an additional 131,300 shares during the period. Point72 Asset Management L.P. purchased a new stake in Mcdonald’s in the 3rd quarter valued at about $13,857,000. Finally, Advisors Asset Management Inc. boosted its position in Mcdonald’s by 8.9% in the 3rd quarter. Advisors Asset Management Inc. now owns 79,599 shares of the fast-food giant’s stock valued at $13,316,000 after buying an additional 6,478 shares during the period. 68.80% of the stock is currently owned by hedge funds and other institutional investors.

NYSE:MCD opened at $191.85 on Tuesday. Mcdonald’s Corp has a 52 week low of $153.13 and a 52 week high of $192.35. The company has a market cap of $146.63 billion, a P/E ratio of 24.28, a PEG ratio of 2.65 and a beta of 0.53.

Mcdonald’s (NYSE:MCD) last posted its earnings results on Wednesday, January 30th. The fast-food giant reported $1.97 EPS for the quarter, beating the Zacks’ consensus estimate of $1.90 by $0.07. Mcdonald’s had a net margin of 28.18% and a negative return on equity of 104.38%. The company had revenue of $5.16 billion during the quarter, compared to analysts’ expectations of $5.16 billion. During the same quarter in the prior year, the company posted $1.71 earnings per share. Mcdonald’s’s revenue for the quarter was down 3.3% compared to the same quarter last year. As a group, equities analysts forecast that Mcdonald’s Corp will post 8.12 EPS for the current fiscal year.

In related news, VP Catherine A. Hoovel sold 1,328 shares of the stock in a transaction that occurred on Thursday, February 14th. The shares were sold at an average price of $175.95, for a total transaction of $233,661.60. Following the completion of the sale, the vice president now owns 2,499 shares of the company’s stock, valued at $439,699.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Robert Lane Gibbs sold 22,036 shares of the company’s stock in a transaction that occurred on Thursday, January 31st. The shares were sold at an average price of $180.95, for a total transaction of $3,987,414.20. The disclosure for this sale can be found here. Insiders have sold 129,775 shares of company stock valued at $23,249,437 in the last three months. 0.22% of the stock is currently owned by corporate insiders.

MCD has been the subject of several research reports. Zacks Investment Research cut shares of Mcdonald’s from a “hold” rating to a “sell” rating in a research report on Tuesday, April 2nd. Royal Bank of Canada reaffirmed a “buy” rating and issued a $205.00 price target on shares of Mcdonald’s in a research report on Wednesday, January 30th. Wells Fargo & Co upped their price target on shares of Mcdonald’s from $202.00 to $203.00 and gave the stock an “outperform” rating in a research report on Friday, January 11th. Stephens raised shares of Mcdonald’s from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $180.00 to $200.00 in a research report on Tuesday, February 19th. Finally, Telsey Advisory Group reaffirmed an “outperform” rating and issued a $210.00 price target (up previously from $195.00) on shares of Mcdonald’s in a research report on Friday, April 5th. Six investment analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $195.50.

ILLEGAL ACTIVITY WARNING: “Kinneret Advisory LLC Buys New Holdings in Mcdonald’s Corp (MCD)” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4296183/kinneret-advisory-llc-buys-new-holdings-in-mcdonalds-corp-mcd.html.

Mcdonald’s Profile

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer various food products, soft drinks, coffee, and other beverages, as well as breakfast menu. As of December 31, 2018, the company operated 37,855 restaurants, including 35,085 franchised restaurants comprising 21,685 franchised to conventional franchisees, 7,225 licensed to developmental licensees, and 6,175 licensed to foreign affiliates; and 2,770 company-operated restaurants.

Read More: Google Finance Portfolio Workaround

Institutional Ownership by Quarter for Mcdonald`s (NYSE:MCD)

Receive News & Ratings for Mcdonald's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mcdonald's and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JMP Securities Reiterates $9.00 Price Target for Ocular Therapeutix
JMP Securities Reiterates $9.00 Price Target for Ocular Therapeutix
Regeneron Pharmaceuticals  Given Hold Rating at JPMorgan Chase & Co.
Regeneron Pharmaceuticals Given Hold Rating at JPMorgan Chase & Co.
Homeserve’s  Buy Rating Reiterated at Berenberg Bank
Homeserve’s Buy Rating Reiterated at Berenberg Bank
American Eagle Outfitters  PT Set at $26.00 by UBS Group
American Eagle Outfitters PT Set at $26.00 by UBS Group
Barclays Begins Coverage on Johnson & Johnson
Barclays Begins Coverage on Johnson & Johnson
ASX LTD/ADR  Getting Somewhat Positive Media Coverage, Report Finds
ASX LTD/ADR Getting Somewhat Positive Media Coverage, Report Finds


© 2006-2019 Ticker Report